Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma

NCT00540644 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: lenalidomide (Revlimid®)
DRUG: Cyclophosphamide
DRUG: Prednisone

Sponsor

Attaya Suvannasankha

Collaborators

[object Object]